Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis-Reference-Cited by-同舟云学术

Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis

Published:2013-10-17 Issue:6 Volume:58 Page:2045-2055
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Boonstra Kirsten¹,Weersma Rinse K.²,van Erpecum Karel J.³,Rauws Erik A.¹,Spanier B.W. Marcel⁴,Poen Alexander C.⁵,van Nieuwkerk Karin M.⁶,Drenth Joost P.⁷,Witteman Ben J.⁸,Tuynman Hans A.⁹,Naber Anton H.¹⁰,Kingma Paul J.¹⁰,van Buuren Henk R.¹¹,van Hoek Bart¹²,Vleggaar Frank P.³,van Geloven Nan¹³,Beuers Ulrich¹,Ponsioen Cyriel Y.¹,

Affiliation:

1. Department of Gastroenterology and Hepatology; Academic Medical Center; Amsterdam the Netherlands

2. Department of Gastroenterology and Hepatology; University of Groningen and University Medical Center Groningen; Groningen the Netherlands

3. Department of Gastroenterology and Hepatology; University Medical Center Utrecht; Utrecht the Netherlands

4. Department of Gastroenterology and Hepatology; Rijnstate Hospital; Arnhem the Netherlands

5. Department of Gastroenterology and Hepatology; Isala Clinics; Zwolle the Netherlands

6. Department of Gastroenterology and Hepatology; VU Medical Center; Amsterdam the Netherlands

7. Department of Gastroenterology and Hepatology; Radboud University Nijmegen Medical Center; Nijmegen the Netherlands

8. Department of Gastroenterology and Hepatology; Gelderse Vallei Hospital; Ede the Netherlands

9. Department of Gastroenterology and Hepatology; Medical Center Alkmaar; Alkmaar the Netherlands

10. Department of Gastroenterology and Hepatology; Tergooiziekenhuizen; Hilversum/Blaricum the Netherlands

11. Department of Gastroenterology and Hepatology; Erasmus University Medical Center; Rotterdam the Netherlands

12. Department of Gastroenterology and Hepatology; Leiden University Medical Center; Leiden the Netherlands

13. Clinical Research Unit; Academic Medical Center; Amsterdam the Netherlands

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.26565/fullpdf

Reference41 articles.

1. Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population;Ponsioen;Gut,2002

2. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis;Broomé;Gut,1996

3. Four years experience with short term stenting in primary sclerosing cholangitis;Ponsioen;Am J Gastroenterol,1999

4. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis;Burak;Am J Gastroenterol,2004

5. High lifetime risk of cancer in primary sclerosing cholangitis;Claessen;J Hepatol,2009

Cited by 560 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary sclerosing cholangitis: Is qualitative and quantitative 3 T MR imaging useful for the evaluation of disease severity?;European Journal of Radiology Open;2024-12

2. Hepatic immune regulation and sex disparities;Nature Reviews Gastroenterology & Hepatology;2024-09-05

3. Investigation of abnormal liver blood tests in patients with inflammatory bowel disease;Frontline Gastroenterology;2024-09-02

4. Past, current, and future trends in the prevalence of primary sclerosing cholangitis and inflammatory bowel disease across England (2015–2027): a nationwide, population-based study;The Lancet Regional Health - Europe;2024-09

5. S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV);Zeitschrift für Gastroenterologie;2024-09